Cloverleaf Bio

Private

New Haven, ConnecticutHealthcare & Life Scienceshttps://cloverleafbio.com/

Last Round

Seed

Sep 8, 2026

Total Funding Raised

$33.76M

Company Overview

Cloverleaf Bio is a biotechnology company developing a novel class of engineered tRNA-based therapeutics for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

rna therapeuticsdrug discoverytRNA therapeuticsbiotechtherapeutic platformrna biologydrug developmentbiopharmalicensing agreementr&d partnershiprna medicinenovel therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cloverleaf Bio Comparables

Compare Cloverleaf Bio with similar companies based on industry and business-model similarity.

Cloverleaf Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
HAYA Therapeutics	81%
THERAtRAME	79%
Tevard Biosciences	79%

View all Comparables

Cloverleaf Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Sep 8, 2026
Grant	Sep 15, 2025
Grant	Jun 23, 2025
Accelerator	Oct 30, 2024

View all Funding Rounds

Cloverleaf Bio Investors

Notable investors and investment history

Cloverleaf Bio investors
Investor	Rounds
National Cancer Institute	Grant
4BIO Capital	Seed
AbbVie Ventures	Seed
BrightEdge	Seed
Draper Associates	Seed
Boehringer Ingelheim Venture Fund	Seed
Ono Venture Investment, Inc.	Accelerator

View all Investors

Cloverleaf Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cloverleaf Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cloverleaf Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut

Employee Range5

Year Founded2023

Last FundingSep 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?